craft-sa-dev Home  

PMC:1255741 / 64234-64906 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T15967 0-2 TO denotes To
T15968 3-9 VB denotes assess
T15970 10-16 NN denotes memory
T15971 16-18 , denotes ,
T15972 18-23 IN denotes after
T15973 24-27 CD denotes 280
T15974 28-34 NNS denotes trials
T15975 35-37 IN denotes of
T15976 38-46 NN denotes training
T15977 47-49 TO denotes to
T15978 50-62 VB denotes discriminate
T15979 63-70 IN denotes between
T15980 71-81 JJ denotes pelargonic
T15981 82-86 NN denotes acid
T15982 87-90 CC denotes and
T15983 91-98 JJ denotes valeric
T15984 99-103 NN denotes acid
T15985 103-105 , denotes ,
T15986 105-111 NN denotes memory
T15987 112-118 NNS denotes trials
T15988 119-123 VBD denotes were
T15969 124-135 VBN denotes interleaved
T15990 136-139 IN denotes for
T15991 140-143 CD denotes 120
T15992 144-150 NNS denotes trials
T15993 150-151 : denotes ;
T15994 152-156 RB denotes that
T15995 157-159 RB denotes is
T15996 159-161 , denotes ,
T15997 161-167 IN denotes within
T15998 168-172 DT denotes each
T15999 173-178 NN denotes block
T16000 179-181 IN denotes of
T16001 182-184 CD denotes 20
T16002 185-191 NNS denotes trials
T16003 192-195 CD denotes two
T16005 196-206 JJ denotes unrewarded
T16004 207-218 NN denotes amylacetate
T16006 219-222 CC denotes and
T16007 223-226 CD denotes two
T16009 227-237 JJ denotes unrewarded
T16008 238-251 NN denotes ethylbutyrate
T16010 252-258 NNS denotes trials
T16011 259-263 VBD denotes were
T15989 264-272 VBN denotes included
T16012 272-273 . denotes .
T16013 273-524 sentence denotes Memory scores are given as the fraction of those unrewarded trials that were responded to “correctly” (licking response to the odor that was rewarded in the initial training session [S+], no response to the odor that was not rewarded initially [S−]).
T16014 274-280 NN denotes Memory
T16015 281-287 NNS denotes scores
T16017 288-291 VBP denotes are
T16016 292-297 VBN denotes given
T16018 298-300 IN denotes as
T16019 301-304 DT denotes the
T16020 305-313 NN denotes fraction
T16021 314-316 IN denotes of
T16022 317-322 DT denotes those
T16024 323-333 JJ denotes unrewarded
T16023 334-340 NNS denotes trials
T16025 341-345 WDT denotes that
T16027 346-350 VBD denotes were
T16026 351-360 VBN denotes responded
T16028 361-363 IN denotes to
T16029 364-365 `` denotes “
T16030 365-374 RB denotes correctly
T16031 374-375 '' denotes ”
T16032 376-377 -LRB- denotes (
T16034 377-384 NN denotes licking
T16035 385-393 NN denotes response
T16036 394-396 IN denotes to
T16037 397-400 DT denotes the
T16038 401-405 NN denotes odor
T16039 406-410 WDT denotes that
T16041 411-414 VBD denotes was
T16040 415-423 VBN denotes rewarded
T16042 424-426 IN denotes in
T16043 427-430 DT denotes the
T16045 431-438 JJ denotes initial
T16046 439-447 NN denotes training
T16044 448-455 NN denotes session
T16047 456-457 -LRB- denotes [
T16048 457-458 NN denotes S
T16049 458-459 SYM denotes +
T16050 459-460 -RRB- denotes ]
T16051 460-462 , denotes ,
T16052 462-464 DT denotes no
T16033 465-473 NN denotes response
T16053 474-476 IN denotes to
T16054 477-480 DT denotes the
T16055 481-485 NN denotes odor
T16056 486-490 WDT denotes that
T16058 491-494 VBD denotes was
T16059 495-498 RB denotes not
T16057 499-507 VBN denotes rewarded
T16060 508-517 RB denotes initially
T16061 518-519 -LRB- denotes [
T16062 519-520 NN denotes S
T16063 520-521 SYM denotes −
T16064 521-522 -RRB- denotes ]
T16065 522-523 -RRB- denotes )
T16066 523-524 . denotes .
T16067 524-672 sentence denotes Due to the epileptic phenotype and the slightly increased mortality [58], GluRBΔECS:FB mice were trained only for the initial period of 400 trials.
T16068 525-528 IN denotes Due
T16070 529-531 IN denotes to
T16071 532-535 DT denotes the
T16073 536-545 JJ denotes epileptic
T16072 546-555 NN denotes phenotype
T16074 556-559 CC denotes and
T16075 560-563 DT denotes the
T16077 564-572 RB denotes slightly
T16078 573-582 VBN denotes increased
T16076 583-592 NN denotes mortality
T16079 593-594 -LRB- denotes [
T16080 594-596 CD denotes 58
T16081 596-597 -RRB- denotes ]
T16082 597-599 , denotes ,
T16083 599-608 NN denotes GluRBΔECS
T16085 608-609 : denotes :
T16084 609-611 NN denotes FB
T16086 612-616 NNS denotes mice
T16087 617-621 VBD denotes were
T16069 622-629 VBN denotes trained
T16088 630-634 RB denotes only
T16089 635-638 IN denotes for
T16090 639-642 DT denotes the
T16092 643-650 JJ denotes initial
T16091 651-657 NN denotes period
T16093 658-660 IN denotes of
T16094 661-664 CD denotes 400
T16095 665-671 NNS denotes trials
T16096 671-672 . denotes .
R10658 T15967 T15968 aux To,assess
R10659 T15968 T15969 advcl assess,interleaved
R10660 T15969 T15989 ccomp interleaved,included
R10661 T15970 T15968 dobj memory,assess
R10662 T15971 T15969 punct ", ",interleaved
R10663 T15972 T15969 prep after,interleaved
R10664 T15973 T15974 nummod 280,trials
R10665 T15974 T15972 pobj trials,after
R10666 T15975 T15974 prep of,trials
R10667 T15976 T15975 pobj training,of
R10668 T15977 T15978 aux to,discriminate
R10669 T15978 T15976 acl discriminate,training
R10670 T15979 T15978 prep between,discriminate
R10671 T15980 T15981 amod pelargonic,acid
R10672 T15981 T15979 pobj acid,between
R10673 T15982 T15981 cc and,acid
R10674 T15983 T15984 amod valeric,acid
R10675 T15984 T15981 conj acid,acid
R10676 T15985 T15969 punct ", ",interleaved
R10677 T15986 T15987 compound memory,trials
R10678 T15987 T15969 nsubjpass trials,interleaved
R10679 T15988 T15969 auxpass were,interleaved
R10680 T15990 T15969 prep for,interleaved
R10681 T15991 T15992 nummod 120,trials
R10682 T15992 T15990 pobj trials,for
R10683 T15993 T15989 punct ;,included
R10684 T15994 T15995 advmod that,is
R10685 T15995 T15989 advmod is,included
R10686 T15996 T15989 punct ", ",included
R10687 T15997 T15989 prep within,included
R10688 T15998 T15999 det each,block
R10689 T15999 T15997 pobj block,within
R10690 T16000 T15999 prep of,block
R10691 T16001 T16002 nummod 20,trials
R10692 T16002 T16000 pobj trials,of
R10693 T16003 T16004 nummod two,amylacetate
R10694 T16004 T15989 nsubjpass amylacetate,included
R10695 T16005 T16004 amod unrewarded,amylacetate
R10696 T16006 T16004 cc and,amylacetate
R10697 T16007 T16008 nummod two,ethylbutyrate
R10698 T16008 T16010 compound ethylbutyrate,trials
R10699 T16009 T16008 amod unrewarded,ethylbutyrate
R10700 T16010 T16004 conj trials,amylacetate
R10701 T16011 T15989 auxpass were,included
R10702 T16012 T15989 punct .,included
R10703 T16014 T16015 compound Memory,scores
R10704 T16015 T16016 nsubjpass scores,given
R10705 T16017 T16016 auxpass are,given
R10706 T16018 T16016 prep as,given
R10707 T16019 T16020 det the,fraction
R10708 T16020 T16018 pobj fraction,as
R10709 T16021 T16020 prep of,fraction
R10710 T16022 T16023 det those,trials
R10711 T16023 T16021 pobj trials,of
R10712 T16024 T16023 amod unrewarded,trials
R10713 T16025 T16026 dep that,responded
R10714 T16026 T16023 relcl responded,trials
R10715 T16027 T16026 auxpass were,responded
R10716 T16028 T16026 prep to,responded
R10717 T16029 T16026 punct “,responded
R10718 T16030 T16026 advmod correctly,responded
R10719 T16031 T16026 punct ”,responded
R10720 T16032 T16033 punct (,response
R10721 T16033 T16026 parataxis response,responded
R10722 T16034 T16035 compound licking,response
R10723 T16035 T16033 dep response,response
R10724 T16036 T16035 prep to,response
R10725 T16037 T16038 det the,odor
R10726 T16038 T16036 pobj odor,to
R10727 T16039 T16040 dep that,rewarded
R10728 T16040 T16038 relcl rewarded,odor
R10729 T16041 T16040 auxpass was,rewarded
R10730 T16042 T16040 prep in,rewarded
R10731 T16043 T16044 det the,session
R10732 T16044 T16042 pobj session,in
R10733 T16045 T16044 amod initial,session
R10734 T16046 T16044 compound training,session
R10735 T16047 T16048 punct [,S
R10736 T16048 T16035 parataxis S,response
R10737 T16049 T16048 punct +,S
R10738 T16050 T16048 punct ],S
R10739 T16051 T16033 punct ", ",response
R10740 T16052 T16033 det no,response
R10741 T16053 T16033 prep to,response
R10742 T16054 T16055 det the,odor
R10743 T16055 T16053 pobj odor,to
R10744 T16056 T16057 dep that,rewarded
R10745 T16057 T16055 relcl rewarded,odor
R10746 T16058 T16057 auxpass was,rewarded
R10747 T16059 T16057 neg not,rewarded
R10748 T16060 T16057 advmod initially,rewarded
R10749 T16061 T16062 punct [,S
R10750 T16062 T16033 parataxis S,response
R10751 T16063 T16062 punct −,S
R10752 T16064 T16062 punct ],S
R10753 T16065 T16033 punct ),response
R10754 T16066 T16016 punct .,given
R10755 T16068 T16069 prep Due,trained
R10756 T16070 T16068 pcomp to,Due
R10757 T16071 T16072 det the,phenotype
R10758 T16072 T16068 pobj phenotype,Due
R10759 T16073 T16072 amod epileptic,phenotype
R10760 T16074 T16072 cc and,phenotype
R10761 T16075 T16076 det the,mortality
R10762 T16076 T16072 conj mortality,phenotype
R10763 T16077 T16078 advmod slightly,increased
R10764 T16078 T16076 amod increased,mortality
R10765 T16079 T16080 punct [,58
R10766 T16080 T16076 parataxis 58,mortality
R10767 T16081 T16080 punct ],58
R10768 T16082 T16069 punct ", ",trained
R10769 T16083 T16084 nmod GluRBΔECS,FB
R10770 T16084 T16086 compound FB,mice
R10771 T16085 T16084 punct :,FB
R10772 T16086 T16069 nsubjpass mice,trained
R10773 T16087 T16069 auxpass were,trained
R10774 T16088 T16089 advmod only,for
R10775 T16089 T16069 prep for,trained
R10776 T16090 T16091 det the,period
R10777 T16091 T16089 pobj period,for
R10778 T16092 T16091 amod initial,period
R10779 T16093 T16091 prep of,period
R10780 T16094 T16095 nummod 400,trials
R10781 T16095 T16093 pobj trials,of
R10782 T16096 T16069 punct .,trained